Endoprosthetic Reconstruction of the Upper Extremity in Oncologic Surgery.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 17. J Orthop Traumatol. 2014 Jun;15(2):81-6. doi: 10.1007/s10195-013-0265-8. Epub 2013 Sep 22. From amputation to limb salvage reconstruction: evolution and role of the endoprosthesis in musculoskeletal oncology. Hwang JS(1), Mehta AD, Yoon RS, Beebe KS. Author information: (1)Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, 07101, USA, jhwang12@gmail.com. In 1943, Austin Moore developed the first endoprosthesis fashioned from Vitallium, providing the first alternative to traditional amputation as primary treatment of bone tumors. The success of the Vitallium endoprosthesis has since then led to the development of new materials and designs further advancing limb salvage and reconstructive surgery. Combined with the advent of chemotherapy use and imaging advances, conservative treatment of musculoskeletal tumors has expanded greatly. As the implantable options increased with the development of the Lewis expandable adjustable prosthesis and the noninvasive Phenix Growing prosthesis, receiving the diagnosis of a bone tumor no longer equates to automatic limb loss. Our review details the history and development of endoprostheses throughout orthopedic oncology in the treatment of musculoskeletal tumors. DOI: 10.1007/s10195-013-0265-8 PMCID: PMC4033797